BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 23, 2012
View Archived Issues
Orion discloses new androgen receptor antagonists
Read More
Novel nicotinic acetylcholine receptor ligands synthesized at CNRS and INSERM
Read More
Niacin analogue ARI-3037-MO evaluated in healthy subjects
Read More
GSK-1292263 markedly reduces lipids in nondiabetic subjects
Read More
European Institute of Oncology and University of Pisa sign oncology agreement
Read More
Dainippon Sumitomo Pharma and Shionogi to launch Aimix in Japan
Read More
Teriflunomide approved in Australia for multiple sclerosis
Read More
Votrient now available in Japan
Read More
Preclinical pharmacokinetics and efficacy of a potent MEK inhibitor presented
Read More
Novartis launches Sosei's inhalation capsule for COPD in Japan
Read More
FDA approves first cell culture-produced seasonal influenza vaccine
Read More
MedWell presents promising preclinical results for a novel drug candidate
Read More
Joyant Pharmaceuticals presents novel agents for cancer
Read More
Canadian group patents new androgen receptor ligands
Read More
FDA accepts resubmission of Levadex NDA
Read More
TRIM28 as a potential biomarker of high risk colorectal cancer
Read More
Gilead Sciences discloses novel agents for AIDS
Read More
Emory University and Wake Forest University synthesize new NET ligands
Read More
Neuren completes phase I NNZ-2566 study and files phase II IND
Read More
Study of alpha-1-antitrypsin drug shows efficacy and safety in type 1 diabetes
Read More
Basilea begins new phase I study of BAL-30072
Read More
Korean researchers patent novel agents for viral infections
Read More
Nihon Medi-Physics files for approval of NMA-78 in Japan
Read More
Cardio3 BioSciences gains clearance for phase III trial of regenerative heart failure therapy
Read More
ERYtech Pharma grants exclusive European rights for anticancer product to Orphan Europe
Read More
